Erythropoiesis-stimulating agents in cancer patients: reflections on safety. - Wikidata - wikimedia - TriplyDB

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

http://www.wikidata.org/entity/Q37960528

about

Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials.Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy.

P2860

Q38033247-618B75E4-D9CC-4BB7-8312-AE4199C1E31F Q38056750-55E25019-3102-48F6-845F-F6D20B7AEE5C

P2860

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

http://www.wikidata.org/entity/Q37960528

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

@en

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

@nl

type

label

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

@en

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

@nl

prefLabel

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

@en

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

@nl

P1433

Q37960528-413FE7A8-915E-411F-B745-A5F59DB04BD3

P1476

Q37960528-E9B96B2B-6F9F-4E29-AE51-DE2D10886E56

P2093

Q37960528-1C76E576-E08D-4DC3-A2B2-1543CC7C325F

Q37960528-9D71FCC6-AD32-4493-B4AC-EC8DBC5826DE

P2860

Q37960528-054D76DB-EF17-4DF6-94DA-D070299CBCA7

Q37960528-0A0C3D98-28AB-429B-B64C-FAD4263A0AF9

Q37960528-0B404E71-1A4D-4230-8CF0-CE0557A0B51B

Q37960528-0EBB0305-14A7-4594-8CBB-E4C4EF35DC3B

Q37960528-246F103D-3D71-47D9-80CE-DDAA689E5606

Q37960528-2FD511F1-7DDE-4C24-AAA8-43F4B34510FA

Q37960528-3BC73A95-435E-4A7C-BB08-B9641CE81CDF

Q37960528-4221768D-9934-43E0-880F-48D0CCAE8D7D

Q37960528-463693FB-36FB-4DA1-8DAC-77DB0761CD3E

Q37960528-47F31911-19D6-43FF-8D23-EB96A5E74C18

P304

Q37960528-084101AA-192E-4D82-94B9-5FD8EE70BF59

P31

Q37960528-5108B6D8-05A0-4FB8-B1A3-B2F7A34AEAC1

P356

Q37960528-DF1BFBB4-C39C-4C1F-93F5-2F82C75A3E8C

P407

Q37960528-8D9C4346-7BC3-4BF6-8CB0-D88664C3B2AC

P433

Q37960528-17A61C8C-2754-40DC-B859-42019D7493B9

P478

Q37960528-2CFBDC06-705C-43C1-AA39-53E0C432EBD6

P577

Q37960528-768DA032-69EB-4E2C-AB16-34FCFF2780D7

P698

Q37960528-BAD232C2-AAF7-45A9-AB2E-9E784404948A

P356

P1433

Expert Review of Clinical Pharmacology

P1476

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

@en

P2093

Isabelle Wauters

http://www.w3.org/2001/XMLSchema#string

Johan Vansteenkiste

http://www.w3.org/2001/XMLSchema#string

P2860

September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents

Cloning and expression of the human erythropoietin gene

The erythropoietin receptor in normal and cancer tissues

Hypoxia in cancer: significance and impact on clinical outcome

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.

Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

P304

467-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECP.11.22

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22114856

http://www.w3.org/2001/XMLSchema#string